biomaterials
-
Recon
Superior Polymers Releases Groundbreaking Medical-Grade PEEK Composite Combining Carbon Fiber, Hydroxyapatite, and Polyether Ether Ketone for Medical Applications
First combination of three clinically proven biomaterials now available for the manufacture of medical devices such as spinal and cardiovascular…
Read More » -
Biologics
HippoFi Begins 2023 with Strong Sales of Advanced Biomaterials
Expanded sales force fuels market growth. IRVINE, CA., January 13, 2023 /OrthoSpineNews/ – HippoFi, Inc. (formerly ORHub), (OTC Pink: ORHB),…
Read More » -
Biologics
DiFusion Technologies, Inc. Announces Landmark Data for the Company’s ZFUZE Surgical Polymer
June 2, 2021 AUSTIN, Texas–(BUSINESS WIRE)–DiFusion Technologies, Inc. today announced landmark data for the company’s ZFUZE Surgical Polymer and how…
Read More » -
Biologics
Implantable Medical Devices Market to Reach US$49.8 Billion by 2024 End, Manufacturers Focus on Improving Biomaterial Design and Functionality, Says TMR
ALBANY, New York, December 19, 2018 /PRNewswire/ — The global implantable medical devices market stood at US$32.3 billion in 2015. Expanding at a CAGR of 4.9%…
Read More » -
Biologics
University of Helsinki Finland has developed nanofibers and thin-film biomaterials as orthopedic scaffolds to help regenerate bones and to help implants
Posted on January 22, 2017 by adminedit Chemists at the University of Helsinki have created a method of using nanofibers…
Read More » -
Biologics
Implantable Biomaterials Market Analysis & Trends – Material (Immunomodulatory Biomaterials, Natural, Polymers, Hydrogels and Ceramics), Application- Forecast to 2025
NEW YORK, Jan. 17, 2017 /PRNewswire/ — The Global Implantable Biomaterials Market is poised to grow at a CAGR of around 7.5%…
Read More » -
Biologics
Richard Davies Wins “Best CEO in the Biomaterials Industry” Award from European CEO Magazine
Lund, Sweden, 13 December, 2016 – BONESUPPORT AB, an emerging leader in innovative injectable bioceramic bone scaffolds to treat bone…
Read More » -
Financial
aap completes sale of biomaterials business
aap Implantate AG (“aap”) today completed the sale of 100% of the company shares in its subsidiary aapBiomaterials GmbH. The…
Read More » -
Financial
aap sells Biomaterials Business for EUR 36 Million and becomes a pure player in trauma with innovative technologies
Press Release dated March 22, 2016 aap Implantate AG (“aap”) signed a notarized share purchase agreement today with a leading…
Read More » -
Biologics
Graftys Announces Creation of an International Implant Registry to Follow up Graftys® HBS and Graftys® QuickSet
AIX-EN-PROVENCE, France–(BUSINESS WIRE)–GRAFTYS SA, a company which develops and commercializes biomaterials used in orthopedic surgery, announces that it has recently…
Read More » -
Biologics
Titan Spine Earns Orthopedics This Week 2015 Spine Technology Award
MEQUON, Wisc.–(BUSINESS WIRE)–Titan Spine, a medical device surface technology company focused on developing innovative spinal interbody fusion implants, today announced…
Read More » -
Biologics
Heraeus Medical GmbH and BioTime Subsidiary OrthoCyte Corporation Enter Into Exclusive Worldwide Development and Licensing Agreements
HANAU, Germany & ALAMEDA, Calif.–(BUSINESS WIRE)–Heraeus Medical GmbH, one of the leading companies in the field of bone cement and…
Read More » -
Biologics
Bacterin International Announces Signing of Agreement With Yankee Alliance
BELGRADE, Mont., June 19, 2015 (GLOBE NEWSWIRE) — Bacterin International Holdings, Inc. (OTCQX:BONE), a leader in the development of revolutionary…
Read More » -
Biologics
Bacterin Announces the Launch of ArthroFuse(TM)
BELGRADE, Mont., June 3, 2015 (GLOBE NEWSWIRE) — Bacterin International Holdings, Inc. (OTCQX:BONE), a leader in the development of revolutionary…
Read More »